AUPH
Aurinia Pharmaceuticals Inc
NASDAQ: AUPH · HEALTHCARE · BIOTECHNOLOGY
$16.21
+0.00% today
Updated 2026-11-12
Market cap
$2.17B
P/E ratio
7.11
P/S ratio
6.75x
EPS (TTM)
$2.28
Dividend yield
—
52W range
$14 – $19
Volume
0.9M
Aurinia Pharmaceuticals Inc (AUPH) Financial Forecast & Price Target 2030
Revenue-driven projection model with historical context.
Price target summary
Current price
$16.21
12-Month target
$17.96
2030 Target
—
Intrinsic (DCF)
—
Financial forecast
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $0.0B | $0.1B | $0.2B | $0.2B | $0.3B |
| EPS | — | — | — | — | — |
CAGR applied: — (capped 20%) · P/E: 7.11x (capped 25x) · Margin: 97.70%
Methodology
CAGR-based projection model. Research-backed estimates are being generated — check back soon for analyst consensus and management guidance.